NESANCE Trademark

Trademark Overview


On Thursday, January 12, 2017, a trademark application was filed for NESANCE with the United States Patent and Trademark Office. The USPTO has given the NESANCE trademark a serial number of 87299358. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 29, 2024. This trademark is owned by Glaxo Group Limited. The NESANCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
nesance

General Information


Serial Number87299358
Word MarkNESANCE
Filing DateThursday, January 12, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 29, 2024
Registration Number5289497
Registration DateTuesday, September 19, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 4, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 29, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, March 29, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 19, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 19, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, July 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 14, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 27, 2017NON-FINAL ACTION E-MAILED
Friday, January 27, 2017NON-FINAL ACTION WRITTEN
Friday, January 27, 2017ASSIGNED TO EXAMINER
Thursday, January 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 16, 2017NEW APPLICATION ENTERED